MedTrace Logo

Effect of Metformin Iontophoresis on Knee Osteoarthritis in Postmenopausal Women

NCT07395895 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2026-02-09

No results posted yet for this study

Summary

This study is designed as a randomized, double-blind, placebo-controlled clinical trial with two parallel groups. All participants will receive a standardized physical therapy rehabilitation program. Participants will be randomly allocated into either a study group receiving metformin iontophoresis or a control group receiving placebo iontophoresis. Both participants and outcome assessors will be blinded to group allocation.

Conditions

  • Osteoarthritis in Postmenopausal Women

Interventions

DRUG

Metformin gel Iontophoresis

Metformin gel 2% Iontophoresis Combined with Physical Therapy Rehabilitation

DEVICE

Iontophoresis

Iontophoresis with neutral gel Combined with Physical Therapy Rehabilitation

Sponsors & Collaborators

  • Badr University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2026-04-15
Completion
2026-05-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07395895 on ClinicalTrials.gov